Document Detail

Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.
MedLine Citation:
PMID:  18984459     Owner:  NLM     Status:  MEDLINE    
The prevalence of coronary artery disease (CAD) appears to be much higher in patients with end-stage renal disease (ESRD) undergoing dialysis than in a non-ESRD population. Cardiac death due to myocardial ischemia significantly contributes to the high mortality rate of ESRD patients. However, the method for screening for CAD in ESRD patients has not been established, because the frequency of silent myocardial ischemia is high and examinations requiring stress are often difficult to perform among this population. Myocardial fatty acid imaging may be a new modality to detect myocardial ischemia and identify the group at high risk for cardiac death among ESRD patients without adding any stress.
Masato Nishimura; Toshihiko Ono
Related Documents :
24977129 - Recurrent seizures following focal motor status epilepticus in a patient with non-ketot...
20729229 - The chromosome 9p21 risk locus is associated with angiographic severity and progression...
10404349 - Interval-force relation is unaffected by the presence of cardiomyopathy or coronary art...
21511109 - Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascu...
12127379 - Transcardiac gradient of soluble adhesion molecules predicts progression of coronary ar...
100259 - Effect of sublingual nitroglycerin on regional flow in patients with and without corona...
11691519 - Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with pro...
7520789 - Expression of e-selectin on coronary endothelium after myocardial ischemia and reperfus...
3883929 - Ventricular exclusion during fontan operation: an evolving technique.
Publication Detail:
Type:  Journal Article     Date:  2008-09-16
Journal Detail:
Title:  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology     Volume:  15     ISSN:  1532-6551     ISO Abbreviation:  J Nucl Cardiol     Publication Date:    2008 Nov-Dec
Date Detail:
Created Date:  2008-11-05     Completed Date:  2009-04-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423534     Medline TA:  J Nucl Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  830-7     Citation Subset:  IM    
Cardiovascular Division, Toujinkai Hospital, Fushimi-ku, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Coronary Angiography / methods
Fatty Acids / metabolism*
Heart / radionuclide imaging
Kidney Failure, Chronic / diagnosis*,  radionuclide imaging
Myocardial Ischemia / pathology
Myocardium / pathology*
Oxygen / chemistry,  metabolism
Renal Dialysis
Reproducibility of Results
Sensitivity and Specificity
Tomography, Emission-Computed, Single-Photon / methods*
Reg. No./Substance:
0/Fatty Acids; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study.
Next Document:  The global impact of hepatic fibrosis and end-stage liver disease.